Arcadia Biosciences, Inc.
Arcadia Biosciences, Inc. (RKDA) Stock Overview
Explore Arcadia Biosciences, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
5.9M
P/E Ratio
-2.87
EPS (TTM)
$-0.57
ROE
-0.22%
RKDA Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Arcadia Biosciences, Inc. (RKDA) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 38.26, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $1.16.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -2.87 and a market capitalization of 5.9M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.